drugset / Trial / NCT02283710

The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease

NCT02283710

Phase 2 Completed 120 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized double blind clinical trial was performed in patients with non-alcoholic fatty liver disease.They were randomly assigned to lifestyle modification alone or lifestyle modification plus Pentoxifylline groups. Liver function tests, metabolic profile and anthropometric measurements were checked at baseline and six months later.

Timeline

Start
2013-05
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 600 mg

Indications